Percutaneous Coronary Intervention
FIRE: Complete revascularization benefits older patients with MI, multivessel disease
In patients aged 75 years or older with MI and multivessel CAD, physiology-guided complete revascularization improved outcomes compared with treating the culprit lesion only, according to the results of the FIRE trial.
FDA designates recall of two intra-aortic balloon pumps as class I
The FDA announces a recall of intra-aortic balloon pumps manufactured by Datascope/Maquet/Getinge due to risk for unexpected shutdown due to electrical failure in the power management or solenoid boards.
Complete revascularization likely improves HF risk in those with ACS plus multivessel CAD
Complete revascularization was associated with reduced HF hospitalization and both CV and all-cause death among patients presenting with ACS and multivessel CAD, researchers reported in the Journal of the American Heart Association.
Trials to assess CABG vs. PCI in women, people from underrepresented groups
The Patient-Centered Outcomes Research Institute has awarded nearly $30 million to fund a trial program comparing CABG vs. PCI in women and people from historically underrepresented races and ethnicities with coronary artery disease.
Value of lifestyle, symptom relief underscored in new chronic coronary disease guidelines
Updates on beta-blocker use, revascularization and routine testing and recommendations on healthy lifestyle are among the highlights of a new guideline on the management of patients with chronic coronary disease.
Prognosis after PCI affected by interaction of chronic kidney disease, diabetes in women
Concomitant chronic kidney disease and diabetes was prognostic of all-cause death and MI within 3 years among women undergoing drug-eluting stent implantation, according to new data.
Safety of percutaneous microaxial LVAD for cardiogenic shock uncertain vs. other options
For patients presenting with acute MI with cardiogenic shock, the safety of percutaneous microaxial left ventricular assist device use vs. other treatments could not be well established using observational Medicare data, findings show.
Novel percutaneous VAD for high risk-PCI feasible, safe in small study
Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI, a speaker reported.
In STEMI, women less likely than men to receive PCI, survive to 1 year in India
Among patients with STEMI in India, women were less likely to receive PCI and more likely to die at 1 year than men, researchers reported in JACC: Asia.
Virtual roadmap tool may improve safety during PCI, reducing contrast volume, radiation
A virtual PCI road mapping tool could increase procedural safety vs. conventional angiography by reducing contrast volume and the number of angiograms necessary, a speaker reported.